Skip to main content
. 2023 Mar 8;41(2):296–305. doi: 10.1007/s10637-022-01325-4

Fig. 2.

Fig. 2

Antitumor activity for patients with HGG. a Best response in target lesion. The dotted lines at − 50% and 25% indicate boundaries for response and progression, respectively. b Treatment duration, time to best overall response, and time to first progression. Each bar represents an individual patient